The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis

American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text rev. Washington, DC.

Amtmann, 2015, A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis, J. Psychosom. Res., 79, 550, 10.1016/j.jpsychores.2015.08.007

Beck, 1988, An inventory for measuring clinical anxiety: psychometric properties, J. Consult Clin. Psychol., 56, 893, 10.1037/0022-006X.56.6.893

Bland, 1997, Statistics notes: cronbach's alpha, Br. Med. J., 314, 572, 10.1136/bmj.314.7080.572

Cacciola, 1999, Comparability of telephone and In-person structured clinical interview for DSM-III-R (SCID) diagnoses, Assessment, 6, 235, 10.1177/107319119900600304

Cairney, 2007, Evaluation of 2 measures of psychological distress as screeners for depression in the general population, Can. J. Psychiatry, 52, 111, 10.1177/070674370705200209

Fiest, 2015, Comorbidity is associated with pain-related activity limitations in multiple sclerosis, Mult. Scler. Relat. Disord., 4, 470, 10.1016/j.msard.2015.07.014

First, 2002

Fisk, 2002, Construction and validation of a fatigue impact scale for daily administration (D-FIS), Qual. Life Res., 11, 263, 10.1023/A:1015295106602

Hedayati, 2009, Validation of depression screening scales in patients with CKD, Am. J. Kidney Dis., 54, 433, 10.1053/j.ajkd.2009.03.016

Hind, 2016, The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies, BMC Psychiatry, 16, 1, 10.1186/s12888-016-0931-5

Honarmand, 2009, Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients, Mult. Scler., 15, 1518, 10.1177/1352458509347150

Janssens, 2003, Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis, Mult. Scler., 9, 397, 10.1191/1352458503ms930oa

Koo, 2016, A guideline of selecting and reporting intraclass correlation coefficients for reliability research, J. Chiropr. Med., 15, 155, 10.1016/j.jcm.2016.02.012

Kroenke, 2003, The patient health questionnaire-2: validity of a two-item depression screener, Med. Care, 41, 1284, 10.1097/01.MLR.0000093487.78664.3C

Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444

Litster, 2016, Screening tools for anxiety in persons with multiple sclerosis: a systematic review, Int. J. MS Care, 18, 273, 10.7224/1537-2073.2016-004

Marrie, 2015, The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review, Mult. Scler. J., 21, 305, 10.1177/1352458514564487

Marrie, 2015, Comorbidity increases the risk of hospitalizations in multiple sclerosis, Neurology, 84, 350, 10.1212/WNL.0000000000001187

Marrie, 2017, A prospective study of the effects of psychiatric comorbidity in immune-mediated inflammatory disease: rationale, protocol and participation, JMIR Research Protocols

Marrie, 2016, Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study, Neurology, 86, 1279, 10.1212/WNL.0000000000002481

McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis, Ann. Neurol., 50, 121, 10.1002/ana.1032

Mohr, 1997, Identification of beck depression inventory items related to multiple sclerosis, J. Behav. Med., 20, 407, 10.1023/A:1025573315492

Mokkink, 2010, The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes, J. Clin. Epidemiol., 63, 737, 10.1016/j.jclinepi.2010.02.006

Norman, 2006, Development and validation of an overall anxiety severity and impairment scale (OASIS), Depress. Anxiety, 23, 245, 10.1002/da.20182

Patten, 2015, Validity of four screening scales for major depression in MS, Mult. Scler. J., 21, 1064, 10.1177/1352458514559297

Pietrzak, 2012, Subsyndromal depression in the United States: prevalence, course, and risk for incident psychiatric outcomes, Psychol. Med., 1

Pilkonis, 2011, Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS(R)): depression, anxiety, and anger, Assessment, 18, 263, 10.1177/1073191111411667

Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann. Neurol., 69, 292, 10.1002/ana.22366

Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria, Ann. Neurol., 58, 840, 10.1002/ana.20703

Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol., 13, 227, 10.1002/ana.410130302

Ritvo, 1997

Ritvo, 1997

Rohde, 1997, Comparability of telephone and face-to-face interviews in assessing axis I and II disorders, Am. J. Psychiatry, 154, 1593, 10.1176/ajp.154.11.1593

Spitzer, 2006, A brief measure for assessing generalized anxiety disorder: the GAD-7, Arch. Intern. Med., 166, 1092, 10.1001/archinte.166.10.1092

Spitzer, 1999, Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study, JAMA, 282, 1737, 10.1001/jama.282.18.1737

Stafford, 2007, Validity of the hospital anxiety and depression scale and patient health questionnaire-9 to screen for depression in patients with coronary artery disease, Gen. Hosp. Psychiatry, 29, 417, 10.1016/j.genhosppsych.2007.06.005

Terrill, 2015, The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis, Int. J. MS Care, 17, 49, 10.7224/1537-2073.2014-008

Watson, 2014, Validation of mood measures for people with multiple sclerosis, Int. J. MS Care, 16, 105, 10.7224/1537-2073.2013-013

Williams, 2002, Identifying depression in primary care: a literature synthesis of case-finding instruments, General. Hosp. Psychiatry, 24, 225, 10.1016/S0163-8343(02)00195-0

Youden, 1950, Index for rating diagnostic tests, Cancer, 32, 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3

Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr. Scand., 67, 361, 10.1111/j.1600-0447.1983.tb09716.x